title: [Investigation of allergic reactions to platinum salts].
abstract: BACKGROUND
  We report two cases occurring in 2004 of patients being treated for pleural mesothelioma with a combination of cisplatin or carboplatin and pemetrexed. Investigation by skin tests and flow cytometry confirmed the clinical diagnosis in both cases.
  
  
  METHODS
  Case 1: a man of 62 developed, after 12 courses of cisplatin-pemetrexed, an anaphylactic reaction 5 minutes after the infusion of cisplatin. Treatment was withdrawn permanently. Case 2: a man of 66 developed, after 7 courses of cisplatin-pemetrexed, an anaphylactic reaction within the first minute of the infusion of cisplatin. Subsequently, in March 2004, he received pemetrexed alone without any problems. In August 2004 he was prescribed carboplatin-pemetrexed. Within 5 minutes he developed urticaria, pruritus and abdominal pain. He was treated later with pemetrexed alone with no problems.
  
  
  CONCLUSIONS
  Hypersensitivity to platinum salts usually occurs after several courses of treatment. Skin tests and flow cytometry are a simple, concordant, and reliable way of confirming the diagnosis.
authors.affiliation: Service de Pathologie Respiratoire, CHU de Limoges, Limoges, France.
authors.forename: F
authors.initials: F
authors.lastname: Touraine
authors.forename: J
authors.initials: J
authors.lastname: Sainte Laudy
authors.forename: A
authors.initials: A
authors.lastname: Boumediene
authors.forename: F
authors.initials: F
authors.lastname: Ndikumwenayo
authors.forename: C
authors.initials: C
authors.lastname: Decroisette
authors.forename: B
authors.initials: B
authors.lastname: Melloni
authors.forename: A
authors.initials: A
authors.lastname: Vergnenegre
authors.forename: F
authors.initials: F
authors.lastname: Bonnaud
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005434:Flow Cytometry / Q000379:methods; D005971:Glutamates / Q000008:administration & dosage; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy; D008875:Middle Aged; D000068437:Pemetrexed; D010997:Pleural Neoplasms / Q000188:drug therapy; D012882:Skin Tests / Q000379:methods
chemical_list: D000964:Antimetabolites, Antineoplastic; D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine; D016190:Carboplatin; D002945:Cisplatin